Mizuho Lifts Waystar Price Target to $50 on Robust Third-Quarter Results
Mizuho Securities has increased its 12-month price target for Waystar Holding Corp. (NASDAQ: WAY) to $50 from $48 and reaffirmed an “Outperform” rating after the health-technology company reported stronger-than-expected third-quarter earnings. The target revision and rating confirmation were announced on October 30, 2025, one day after the company issued its financial report for the three months ended […]